fiona-clark2-scaled-e1681965339702

Fiona Clark

Journalist
Fiona is a journalist with more than 20 years’ experience in health writing. She is the author of Menowars, a socio-political look at menopause and women’s health, and has written for The Lancet, Medical Observer and Australian Doctor. She started her career in journalism with the Australian Broadcasting Corporation and spent around a decade on its flagship current affairs programme, Lateline. She is currently based in London and is the founder of Harley Street Emporium, a website that is dedicated to providing evidence-based information to women on menopause and is the founder of the charity, the Menopause Research and Education Fund.

More from this expert

The UK has changed its guidance, should Australia follow suit?

Clinical Articles iconClinical Articles

Three quarters of women experience at least one episode of candidiasis in their lifetime, and for 5-10% of people it can be a recurrent, irritating and uncomfortable intrusion.

Clinical Articles iconClinical Articles

Recurrence is common, but this practical advice can help reduce the risk

Clinical Articles iconClinical Articles

It may be rare, but myasthenia gravis can have a profound impact on quality of life, and rates are rising, as neurologist Dr Fiona Chan explains

Clinical Articles iconClinical Articles

Expert explains what it can and can’t do, and what you can responsibly tell your patients…

Clinical Articles iconClinical Articles

Sleep expert Dr Anup Desai runs through assessing the risks and responsibilities.

Clinical Articles iconClinical Articles

We recap the debate between two world experts at the recent World Congress on Menopause in Melbourne...

Clinical Articles iconClinical Articles

A neurologist myth-busts common migraine misconceptions

Clinical Articles iconClinical Articles

Social media influencers are advocating prophylactic use of MHT for cognition, but what does the evidence say…

Clinical Articles iconClinical Articles

Data showing Mounjaro reduces OCP bioavailability has prompted new guidance for women taking both GLP-1s and MHT...

Clinical Articles iconClinical Articles